NASDAQ · Biotechnology

BiondVax Pharmaceuticals Ltd. (BVXV) Stock

$1.36 +0.74% NASDAQ: BVXV Healthcare

BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage.

Valuation

MetricValue
Price$1.36
Market Cap$4.97M
P/E Ratio-20.89
P/B Ratio-6.15
P/S Ratio0.00
EPS (TTM)$-0.20
52-Week High$11.49
52-Week Low$0.63
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-4.92%
ROA-1.96%
ROCE-44.73%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-12.24
Current Ratio6.15

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-20.0M$-78.0M$1.0M$-35.0M$-11.0M
Net Profit$-23.0M$-124.0M$7.0M$-51.0M$-1.0M
EPS$-35.64$-151.98$6.15$-36.00$-0.20
Op Margin—————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$28.0M$116.0M$18.0M$100.0M$27.0M
Total Liabilities$36.0M$181.0M$22.0M$76.0M$29.0M
Cash$20.0M$72.0M$3.0M$54.0M$14.0M
Borrowings$25.0M$131.0M$21.0M$70.0M$22.0M

Latest News

Meta's AI Push Is Starting to Show Up in Cash Flow GuruFocus.com · Jul 30, 2026 Balkrishna Industries Ltd (BOM:502355) (Q1 2027) Earnings Call Highlights: Record OHT Sales ... GuruFocus.com · Jul 30, 2026 Capgemini SE (CAPMF) (H1 2026) Earnings Call Highlights: Revenue Surges 11. ... GuruFocus.com · Jul 30, 2026 Planisware SA (WBO:PLNW) (H1 2026) Earnings Call Highlights: Revenue Growth Accelerates, AI ... GuruFocus.com · Jul 30, 2026 Samsung Electro-Mechanics Co Ltd (XKRX:009150) (Q2 2026) Earnings Call Highlights: ... GuruFocus.com · Jul 30, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-57.0M$-77.0M$-73.0M$-24.0M$-7.0M
Investing Cash Flow$-47.0M$-15.0M$-12.0M$-1.0M$-2.0M
Financing Cash Flow$84.0M$85.0M$14.0M$68.0M$7.0M
Net Cash Flow$5.0M$-3.0M$-63.0M$45.0M$-3.0M
Free Cash Flow$-81.0M$-84.0M$-79.0M$-25.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.04
EV / EBITDA-2.16
FCF Yield-53.09%
Quick Ratio6.15
Interest Coverage0.00
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APTOAptose Biosciences Inc. $1.71 +100.00% -0.16 $4.36M 0.00%
CYTOAltamira Therapeutics Ltd. $0.30 +100.00% -0.02 $1.13M 0.00%
FRTXFresh Tracks Therapeutics, Inc. $0.94 -0.53% -0.97 $5.59M 0.00%
GMDAGamida Cell Ltd. $0.03 +0.00% -0.08 $4.34M 0.00%
HILSHillstream BioPharma, Inc. $0.24 +5.66% -0.66 $4.17M 0.00%

About BiondVax Pharmaceuticals Ltd.

BiondVax Pharmaceuticals Ltd. is an Israeli-based biopharmaceutical company currently in its development stage. Its core mission involves the research, production, and market introduction of therapeutic products designed for the prevention and treatment of a range of infectious and other medical conditions. The company has established strategic licensing and collaboration agreements with prominent scientific institutions, notably the Max Planck Society and the University Medical Center Göttingen. These partnerships are geared towards the advancement and commercialization of nanosized antibodies (NanoAbs), including a specific candidate for COVID-19, and extending this technology to address various other disease indications. Founded in 2003, BiondVax maintains its corporate headquarters in Jerusalem, Israel.

BiondVax Pharmaceuticals Ltd. is headquartered in IL.

BiondVax Pharmaceuticals Ltd. (BVXV) stock trades at $1.36 with a market capitalization of $4.97M. The stock is valued at a price-to-earnings (P/E) ratio of -20.89, price-to-book of -6.15, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.63 and $11.49, and currently trades 88.2% below its 52-week high.

On profitability, BiondVax Pharmaceuticals Ltd. generates a return on equity (ROE) of -4.92%, return on capital employed of -44.73%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.biondvax.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides